real-world outcomes among patients with metastatic triple-negative breast cancer
Published 3 years ago • 32 plays • Length 5:24Download video MP4
Download video MP3
Similar videos
-
5:20
estimating outcomes in triple negative breast cancer
-
3:56
tesetaxel plus checkpoint inhibitors among patients with metastatic triple-negative breast cancer
-
8:52
real-world outcomes of her2 and tnbc patients recieving neoadjuvant chemotherapy
-
5:00
association between tumor mutational burden and outcomes among patients treated with pembrolizumab..
-
1:17
clinical outcomes in women with metastatic her2-low breast cancer in the real world
-
1:45
real-world clinical outcomes in metastatic breast cancer patients treated with palbociclib
-
1:36
real-word efficacy of sacituzumab govitecan in metastatic triple-negative breast cancer
-
1:19
real-world use of bevacizumab in patients with breast cancer
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
1:22
immunological signatures to predict outcomes in patients with tnbc
-
32:04
educational sessions: "management of special subtypes of tnbc"
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
1:13
crosstalk between triple negative breast cancer and microenvironment | oncotarget
-
7:40
study of carboplatin plus nivolumab in metastatic triple-negative breast cancer
-
1:04:28
harnessing the immune system in the treatment of triple-negative breast cancer
-
2:10
testing and targeted therapy in triple negative breast cancer: 2023 west oncology
-
57:18
translating progress with immunotherapies and targeted agents into improved outcomes in tnbc
-
8:55
survival outcomes from the calgb 40603 study in triple-negative breast cancer
-
2:51
preventing brain metastases in patients with her2 or triple negative breast cancer